mdlinx.realcme.com Open in urlscan Pro
3.222.46.226  Public Scan

Submitted URL: http://email.realcme.com/ls/click?upn=lGLkfsfAz-2BcFqjSkT0A6IRfZ5xUJKBQS1qVWxv8ccMsJhpNqSwi1liMAvvVhQ9Forhz2QEAzEumLH0-2F...
Effective URL: https://mdlinx.realcme.com/learner/course/2866
Submission: On February 08 via api from US — Scanned from DE

Form analysis 2 forms found in the DOM

POST https://mdlinx.realcme.com/learner/player/startcourse/2866

<form action="https://mdlinx.realcme.com/learner/player/startcourse/2866" method="POST">
  <input type="hidden" name="_token" value="VtUHr2r6o2PpF56hBjnBqacXBChjwEOPU28SjOUd">
  <button type="submit" class="course-btn" id="login"> START COURSE </button>
</form>

POST https://mdlinx.realcme.com/learner/player/startcourse/2866

<form action="https://mdlinx.realcme.com/learner/player/startcourse/2866" method="POST">
  <input type="hidden" name="_token" value="VtUHr2r6o2PpF56hBjnBqacXBChjwEOPU28SjOUd">
  <button type="submit" class="course-btn" id="login"> START COURSE </button>
</form>

Text Content

 

 


FEATURED
FEATURED
CONFERENCES
CONFERENCES
QUIZZES
QUIZZES
CAREERS
CAREERS



Logged In As Abdusamed Hassen
 * Profile Settings
 * Logout

Course Library
 * Credits Completed
 * Program Scores
 * Curricula
 * Subject Mastery
 * Planner
 * Unfinished Courses
 * SPVisit Dashboard


PRURIGO NODULARIS: A CAUCASIAN ADULT MALE WITH HISTORY OF UNCONTROLLED PN AND
ASSOCIATED COMORBIDITIES

Dermatology
Curriculum:
Not Just Controlling the Itch: Recent Developments in Treating Prurigo Nodularis
Credits:
0.25 AMA PRA Category 1 Credit(s) ™ 0.25 ANCC Contact Hours 0.25 ACPE
Launch Date:
January 25, 2022
Expiration Date:
January 25, 2023
START COURSE
REMIND ME LATER
 * SET FOR 1 WEEK
 * 
 * SET FOR 2 WEEK
 * 
 * SET FOR 3 WEEK
 * 
 * SET FOR 1 MONTH


PRIMARY AUDIENCE:

Dermatologists, specialty nurse practitioners, specialty physician assistants,
and managed care pharmacists.


RELEVANT TERMS:

Dermatology; pruritus; lesions; nodules; quality of life; angioedema; hives;
off-label agents; wheals; skin; skin of color; differential diagnosis; prurigo
nodularis


COURSE FACULTY

CHESAHNA KINDRED, MD, MBA, FAAD

ASSISTANT PROFESSOR OF DERMATOLOGY
HOWARD UNIVERSITY COLLEGE OF MEDICINE
WASHINGTON, DC
KINDRED HAIR & SKIN CENTER
COLUMBIA, MD

Bio

Dr Chesahna Kindred is a board-certified dermatologist, published research
author, and national speaker. She was recently named “Physician of the Year” by
the Daily Record. Dr Kindred grew up in South Central Los Angeles, an area of
California known for its tough streets and strong community spirit, and a place
where overcoming adversity was not simply a choice, but a way of life. It was
this environment that planted the seed for Dr Kindred’s future in her field,
cultivating a strong ambition and drive to serve her community, empowering
people through beauty.

Growing up, she quickly garnered a reputation for her love of education and her
desire to help others achieve their goals. It was this drive that led her to
pursue a career within the field of dermatology. Dr Kindred began her studies at
the University of Southern California where she received her Bachelor of Science
with a minor in Spanish. She then relocated to Ohio where she continued to push
herself in her educational pursuits, earning not just her MD degree, but also an
MBA at the University of Cincinnati.

Dr Kindred was awarded a full scholarship as a Yates Fellow for the MBA program,
where she was only the third person in the history of University of Cincinnati
to receive the dual MD/MBA degree. She then took up her residency and fellowship
at Howard University, an institution that pioneered Ethnic Dermatology. It was
here that Dr Kindred gained her passion and focus on hair loss and ethnic skin.

Soon after graduating from her dermatology residency at Howard University, Dr
Kindred became a leading dermatologist at MedStar Health in the Baltimore area.
Five years later, she founded Kindred Hair & Skin Center in Columbia, Maryland,
where she treats people of all ages and ethnicities.

Dr Kindred remains on the cutting edge of hair loss treatment, using 3 different
methods of treating hair loss with growth factors, such as PRP, on a regular
basis. Currently, she owns the first dermatology office with a full-service
salon that specializes in hair loss, PeterKINdred Hair & Scalp Wellness Center.
The stylist in the salon is Susan Peterkin, co-founder of the Natural Hair
Industry Convention.

Locally, Dr Kindred is heavily involved in community service, often organizing
health fairs, mentoring aspiring doctors, and working with local churches and
community organizations to help educate and empower the community at large.

Within the field of dermatology, Dr Kindred is:

 * Founder and President, Onyx Medical Society, a society of the National
   Medical Association
 * Chair of the National Medical Association, Dermatology Section
 * Fellow of the American Academy of Dermatology (FAAD)
 * Member of the Women’s Dermatological Society, American Society of
   Dermatologic Surgery, Maryland Dermatologic Society, and Monumental
   Dermatology Society

Outside of dermatology, Dr Kindred is:

 * Leader of the African American Community Roundtable, Health Committee
 * Leader of Celebration Church Health & Wellness Ministry
 * Deacon at Celebration Church at Columbia

Dr Kindred has been featured on:

 * Disney’s Doc McStuffins
 * WMAR Baltimore ABC News
 * WJZ Baltimore CBS News
 * WBFF Baltimore Fox News
 * Dermatology Times

Dr Kindred has several publications concerning an array of dermatologic topics
including co-writing chapters in leading dermatology textbooks. Her publications
include but are not limited to hair loss, skin cancer, and treatments in
patients with skin of color. Philosophically her focus of “Empowering through
beauty” has resonated with patients worldwide. Understanding the desire people
have to feel as beautiful outside as they do within, Dr Kindred helps them
achieve the balance that allows people to feel complete. True beauty is not
about vanity, but instead about empowering one’s self to have the confidence to
live life to the fullest.

SHAWN KWATRA, MD, FAAD

ASSOCIATE PROFESSOR OF DERMATOLOGY AND ONCOLOGY
DIRECTOR, JOHNS HOPKINS ITCH CENTER
JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE
BALTIMORE, MD

Bio

Dr Shawn Kwatra is an Assistant Professor of Dermatology and Director of the
Johns Hopkins Itch Center at the Johns Hopkins University School of Medicine. He
specializes in medical dermatology and is board certified by the American Board
of Dermatology. Dr Kwatra’s areas of clinical expertise include, prurigo
nodularis, chronic pruritus, atopic dermatitis, and dermatology for ethnic skin.

Dr Kwatra obtained his undergraduate degree from Duke University, medical
training at Wake Forest University School of Medicine, and his dermatology
residency training at the Johns Hopkins University School of Medicine.

Dr Kwatra’s primary clinical and translational research interest is in the
pathogenesis and treatment of prurigo nodularis and chronic pruritus. He is a
member of several professional organizations including the American Academy of
Dermatology, the Society for Investigative Dermatology, and is currently serving
on the Board of Directors of the Skin of Color Society.


LEARNING OBJECTIVES

1. ANALYZE clinical data surrounding emerging treatments for PN 2. ASSESS the
efficacy of standard, off-label treatments currently used for PN and residual
burden of disease on patients 3. DEVELOP evaluation criteria for prurigo
nodularis (PN) that incorporates characteristic features, including symptoms,
presentation, and comorbidities 4. DEVISE a treatment plan that encourages
long-term adherence

1. ANALYZE clinical data surrounding emerging treatments for PN 2. ASSESS the
efficacy of standard, off-label treatments currently used for PN and residual
burden of disease on patients 3. DEVELOP evaluation criteria for prurigo
nodularis (PN) that incorporates characteristic features, including symptoms,
presentation, and comorbidities 4. DEVISE a treatment plan that encourages
long-term adherence


COURSE INFORMATION

SPONSORSHIP & SUPPORT
This educational activity is jointly provided by Global Education Group and
Spire Learning.


This activity is supported by educational grants from Sanofi Genzyme and
Regeneron Pharmaceuticals.

 

PROGRAM OVERVIEW

Prurigo nodularis (PN) is a chronic condition mediated by immune and neural
dysregulation and presenting with highly pruritic, hyperkeratotic papules or
nodules; the condition disproportionately affects African American patients
compared to the general population. There are currently no FDA-approved
therapies for the treatment of PN, leading to a high level of variability in
clinical practice and the use of off-label agents; the current treatment
landscape, or lack thereof, highlights the need for a multimodal approach to
therapy and consideration of emerging agents. As a result, many health care
professionals may be unaware of the standard, off-label treatments used, as well
as the clinical data surrounding promising emerging agents for PN management and
as a result, may miss opportunities to deliver evidence-based care. Join our
expert faculty as they discuss patient scenarios utilizing methods to avoid
missed opportunities for the care team, assess the clinical efficacy and safety
of standard off-label, as well as emerging therapies, and ultimately devise
effective treatment plans that encourage long-term adherence and address
residual disease burden for patients with PN.

TARGET AUDIENCE

The target audience will be comprised of dermatologists, specialty nurse
practitioners, specialty physician assistants, and managed care pharmacists.

LEARNING OBJECTIVES

Upon completion of this educational activity, learners should be better able to:

 * ANALYZE clinical data surrounding emerging treatments for PN
 * ASSESS the efficacy of standard, off-label treatments currently used for PN
   and residual burden of disease on patients
 * DEVELOP evaluation criteria for prurigo nodularis (PN) that incorporates
   characteristic features, including symptoms, presentation, and comorbidities
 * DEVISE a treatment plan that encourages long-term adherence


ACCREDITATION AND CREDIT DESIGNATION
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the
accreditation requirements and policies of the Accreditation Council for
Continuing Medical Education (ACCME) through the joint providership of Global
Education Group (Global) and Spire Learning, LLC. Global is accredited by the
ACCME to provide continuing medical education for physicians.

Physician Credit Designation
Global Education Group designates this enduring material for a maximum of 0.25
AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate
with the extent of their participation in the activity.

Nursing Continuing Education
Global Education Group is accredited with distinction as a provider of nursing
continuing professional development by the American Nurses Credentialing
Center’s Commission on Accreditation.

This educational activity for 0.25 contact hour is provided by Global Education
Group. Nurses should claim only the credit commensurate with the extent of their
participation in the activity.

Pharmacist Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Pharmacy
Education as a provider of continuing pharmacy education.


Credit Designation Statement
Global Education Group designates this continuing education activity for 0.25
contact hour(s) (0.025 CEUs) of the Accreditation Council for Pharmacy
Education. (Universal Activity Number - 0530-9999-21-162-H01-P) This is a
knowledge-based activity.

HOW TO RECEIVE CREDIT
There is no fee for this educational activity. To receive credit for your
participation in this educational activity:

 * Read the objectives and other introductory CME information
 * Complete the preassessment prior to the start of the activity
 * Participate in the prurigo nodularis case activity
 * Complete the postassessment with a passing score of 70% and complete the
   evaluation at the conclusion of the activity

If you are seeking credit, you must complete the evaluation at the conclusion of
the activity.

For information about the accreditation of this program, please contact Global
at 303-395-1782 or cme@globaleducationgroup.com 

CONFLICTS OF INTEREST STATEMENT
Global Education Group (Global) adheres to the policies and guidelines,
including the Standards for Integrity and Independence in Accredited CE, set
forth to providers by the Accreditation Council for Continuing Medical Education
(ACCME) and all other professional organizations, as applicable, stating those
activities where continuing education credits are awarded must be balanced,
independent, objective, and scientifically rigorous. All persons in a position
to control the content of an accredited continuing education program provided by
Global are required to disclose all financial relationships with any ineligible
company within the past 24 months to Global. All financial relationships
reported are identified as relevant and mitigated by Global in accordance with
the Standards for Integrity and Independence in Accredited CE in advance of
delivery of the activity to learners. The content of this activity was vetted by
Global to assure objectivity and that the activity is free of commercial bias. 

All relevant financial relationships have been mitigated.

PLANNING COMMITTEE
Chesahna Kindred, MD, MBA, FAAD (Chair)
Assistant Professor of Dermatology
Howard University College of Medicine
Washington, DC
Kindred Hair & Skin Center
Columbia, MD

Disclosures:
Consulting Fees (eg, Advisory Board): Aerolase; Eli Lilly and Company; Sun
Pharmaceuticals; UCB, Inc
Speakers’ Bureau: Aerolase; Eli Lilly and Company; Novartis Pharmaceuticals
Corporation; Nutrafol; Sun Pharmaceuticals; UCB, Inc

Shawn Kwatra, MD, FAAD
Associate Professor of Dermatology and Oncology
Director, Johns Hopkins Itch Center
Johns Hopkins University School of Medicine
Baltimore, MD

Disclosures:
Consulting Fees (eg, Advisory Board): AbbVie Inc; Celldex Therapeutics;
Galderma; Incyte Corp; Kiniksa Pharmaceuticals; Novartis Pharmaceuticals Corp;
Pfizer Inc; Regeneron Pharmaceuticals; Sanofi
Contracted Research: Galderma; Kiniksa Pharmaceuticals; Pfizer Inc; Sanofi

EDUCATIONAL PLANNING COMMITTEE
Global Education Group
Rhys Williams, MSN, FNP-C, RN; Lindsay Borvansky; Andrea Funk; Liddy Knight;
Ashley Cann; No relevant financial relationships with any commercial interests.

Spire Learning
Andrew Kim, Kimberly Miniter, and Mary Simmons have nothing to disclose.

Reviewer
Lindsay Borvansky: No relevant financial relationships with any commercial
interests.

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or
investigational uses of agents that are not indicated by the FDA. Global
Education Group (Global) and Spire Learning do not recommend the use of any
agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and
do not necessarily represent the views of any organization associated with this
activity. Please refer to the official prescribing information for each product
for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired
information to enhance patient outcomes and their own professional development.
The information presented in this activity is not meant to serve as a guideline
for patient management. Any procedures, medications, or other courses of
diagnosis or treatment discussed in this activity should not be used by
clinicians without evaluation of patient conditions and possible
contraindications on dangers in use, review of any applicable manufacturer’s
product information, and comparison with recommendations of other authorities.

PRIVACY POLICY:
Spire Learning Privacy Policy:
Spire Learning, LLC, is committed to protecting the privacy of personal
information from our participants and educational collaborators. Spire maintains
physical, electronic, and procedural safeguards that comply with federal
regulations to protect against the loss, misuse, or alteration of personal
information.
 
Collection and Use of Your Personal Information
The submission of certain personally identifiable information is necessary to
award and track the credits participants may earn after completing an activity.
Required items include first name, last name, degree, and email address. These
items are necessary. Participants are also required to complete an evaluation of
each activity. All evaluative information submitted is collected and retained,
and used by Spire Learning, LLC, to continuously improve the learning
experience.
 
Spire Learning, LLC, will not transfer, sell, or share personal information with
outside parties or otherwise disclose personal information unless required to in
a legal process. Spire will retain your personal data only for the period
necessary to accomplish the stated purposes and to comply with applicable laws. 

COPYRIGHT INFORMATION:
Copyright © 2022 by Spire Learning, LLC and Global Education Group. All rights
reserved including translation into other languages. No part of this publication
or activity may be reproduced or transmitted in any form, by any means, without
prior written permission of Spire Learning, LLC.

 

COURSE VIEWING REQUIREMENTS

Supported Browsers:
Microsoft Edge
Google Chrome 60 or higher
Mozilla Firefox 60 or higher
Apple Safari 11.0 or higher
For video, install the latest version of Quicktime. Supported Phones & Tablets:
iOS 9.3 and higher
Android 7.0 (Nougat or higher)
Microsoft Windows 8
Chrome OS

  Additional Recommendations and Requirements Display Resolution & Color Depth
Resolution
- 960 X 768 minimum
- 1024 X 768 recommended min.

Color Depth
- 8 bits (256 colors) minimum
- 16 bits (High colors) minimum Audio - Microphone
- Speakers or headphones
- Audio recording support Word Processing Software that can open, modify, and
save documents in Rich Text Format (RTF). Microsoft Word and PowerPoint are
recommended.

 



START COURSE
REMIND ME LATER
 * SET FOR 1 WEEK
 * 
 * SET FOR 2 WEEK
 * 
 * SET FOR 3 WEEK
 * 
 * SET FOR 1 MONTH

© 2008-2022 RealCME. All rights reserved.
 * Home
 * Support
 * Privacy Policy
 * Terms of Service
 * Contact Us




ERROR


OK

COMING SOON

Coming Soon

OK

SCHEDULE AN EVENT WITH A STANDARDIZED PATIENT

×



Confirm the time